Casdin Capital »

Quest Diagnostics Incorporated shares owned by Casdin Capital

Quarter-by-quarter ownership of Quest Diagnostics Incorporated (DGX) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Quest Diagnostics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Quest Diagnostics Incorporated held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Quest Diagnostics Incorporated by Casdin Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.7M 50k 173.53

More positions owned by Casdin Capital

Genedx Holdings Corp Com Cl A (WGS)
Revolution Medicines (RVMD)
Biolife Solutions Com New (BLFS)
D Fluidigm Corp Del (LAB)
Relay Therapeutics (RLAY)
Structure Therapeutics Sponsored Ads (GPCR)
Illumina (ILMN)
Avidity Biosciences Ord (RNA)
Beam Therapeutics (BEAM)
Guardant Health (GH)
Maze Therapeatics (MAZE)
Denali Therapeutics (DNLI)
Alnylam Pharmaceuticals (ALNY)
Neurogene (NGNE)
10x Genomics Cl A Com (TXG)

View all positions for Casdin Capital

Top funds holding Quest Diagnostics Incorporated

Vanguard Group
BlackRock
State Street Corporation
Jpmorgan Chase & Co
Robeco Investment Management
Geode Capital Management
Victory Capital Management
Dimensional Fund Advisors
Grantham, Mayo, Van Otterloo & Co
Wells Fargo & Company
Goldman Sachs Group
Invesco
Edgepoint Investment
Davis Selected Advisers
Wellington Management Company

View all funds holding Quest Diagnostics Incorporated